These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35945786)

  • 1. Effects of magnesium valproate adjuvant therapy on patients with dementia: A systematic review and meta-analysis.
    Zhang C; Sun L; Sun H
    Medicine (Baltimore); 2022 Aug; 101(31):e29642. PubMed ID: 35945786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnesium valproate adjuvant therapy on patients with dementia: A protocol for systematic review and meta-analysis.
    Zhang CQ; Zheng KX; Sun LQ; Sun H
    Medicine (Baltimore); 2021 Dec; 100(51):e28161. PubMed ID: 34941069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproate preparations for agitation in dementia.
    Lonergan E; Luxenberg J
    Cochrane Database Syst Rev; 2009 Jul; (3):CD003945. PubMed ID: 19588348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of ginkgo preparation in patients with vascular dementia: A protocol for systematic review and meta-analysis.
    Wang M; Peng H; Peng Z; Huang K; Li T; Li L; Wu X; Shi H
    Medicine (Baltimore); 2020 Sep; 99(37):e22209. PubMed ID: 32925798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of valproic acid in dementia: A systematic review with meta-analysis.
    Liu J; Wang LN
    Arch Gerontol Geriatr; 2020; 89():104091. PubMed ID: 32413690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omega-3 fatty acids for the treatment of dementia.
    Burckhardt M; Herke M; Wustmann T; Watzke S; Langer G; Fink A
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD009002. PubMed ID: 27063583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonpharmacological therapies in Alzheimer's disease: a systematic review of efficacy.
    Olazarán J; Reisberg B; Clare L; Cruz I; Peña-Casanova J; Del Ser T; Woods B; Beck C; Auer S; Lai C; Spector A; Fazio S; Bond J; Kivipelto M; Brodaty H; Rojo JM; Collins H; Teri L; Mittelman M; Orrell M; Feldman HH; Muñiz R
    Dement Geriatr Cogn Disord; 2010; 30(2):161-78. PubMed ID: 20838046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a core outcome set for disease modification trials in mild to moderate dementia: a systematic review, patient and public consultation and consensus recommendations.
    Webster L; Groskreutz D; Grinbergs-Saull A; Howard R; O'Brien JT; Mountain G; Banerjee S; Woods B; Perneczky R; Lafortune L; Roberts C; McCleery J; Pickett J; Bunn F; Challis D; Charlesworth G; Featherstone K; Fox C; Goodman C; Jones R; Lamb S; Moniz-Cook E; Schneider J; Shepperd S; Surr C; Thompson-Coon J; Ballard C; Brayne C; Burke O; Burns A; Clare L; Garrard P; Kehoe P; Passmore P; Holmes C; Maidment I; Murtagh F; Robinson L; Livingston G
    Health Technol Assess; 2017 May; 21(26):1-192. PubMed ID: 28625273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS.
    Lyketsos CG; DelCampo L; Steinberg M; Miles Q; Steele CD; Munro C; Baker AS; Sheppard JM; Frangakis C; Brandt J; Rabins PV
    Arch Gen Psychiatry; 2003 Jul; 60(7):737-46. PubMed ID: 12860778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selegiline for Alzheimer's disease.
    Birks J; Flicker L
    Cochrane Database Syst Rev; 2003; (1):CD000442. PubMed ID: 12535396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis.
    Battle CE; Abdul-Rahim AH; Shenkin SD; Hewitt J; Quinn TJ
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013306. PubMed ID: 33704781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproic acid for agitation in dementia.
    Lonergan ET; Cameron M; Luxenberg J
    Cochrane Database Syst Rev; 2004; (2):CD003945. PubMed ID: 15106227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life in dementia: the role of non-cognitive factors in the ratings of people with dementia and family caregivers.
    Sousa MF; Santos RL; Arcoverde C; Simões P; Belfort T; Adler I; Leal C; Dourado MC
    Int Psychogeriatr; 2013 Jul; 25(7):1097-105. PubMed ID: 23561627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Danggui-Shaoyao-San for dementia: A PRISMA-compliant systematic review and meta-analysis.
    Kim Y; Cho SH
    Medicine (Baltimore); 2020 Jan; 99(4):e18507. PubMed ID: 31977846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donepezil for dementia due to Alzheimer's disease.
    Birks JS; Harvey RJ
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD001190. PubMed ID: 29923184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
    Farina N; Llewellyn D; Isaac MGEKN; Tabet N
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002854. PubMed ID: 28418065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Yukmijihwang-tang on symptoms of Alzheimer disease: A protocol for systematic review and meta-analysis.
    Lee S; Kwon DH; Kim JY; Kim Y; Cho SH; Jung IC
    Medicine (Baltimore); 2021 Jun; 100(25):e26363. PubMed ID: 34160408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of sleep disorders and behavioral and psychological symptoms of dementia in late-onset Alzheimer disease: A study in Eastern China.
    Zhou G; Liu S; Yu X; Zhao X; Ma L; Shan P
    Medicine (Baltimore); 2019 Dec; 98(50):e18405. PubMed ID: 31852160
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.